Grace Therapeutics, Inc. (NASDAQ:GRCE) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of private placement financing Update: about US$10M · US$2.1 a share · Craig-Hallum Dealers: Craig-Hallum (lead) Use of proceeds: Support the manufacturing and regulatory work needed to advance GTx-104 | Aug 13, 2026 |
| Warrant exercise of common stock on exercise of common warrants Closed: US$4M raised · US$3.003 a share | Oct 23, 2025 |
| Private placement of securities with accompanying warrants Closed: US$15M raised Buyers: Nantahala Capital (co-led the financing); ADAR1 Partners, LP (co-led the financing); Stonepine Capital Management Use of proceeds: Pre-commercial planning, commercial team build out and product launch of GTx-104 if approved | Feb 13, 2025 |